Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1471

1.

Synaptic signalling and its interface with neuropathologies: snapshots from the past, present and future.

Beart PM.

J Neurochem. 2016 May 4. doi: 10.1111/jnc.13598. [Epub ahead of print]

PMID:
27144305
2.

Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations.

Nikolakopoulou AM, Georgakopoulos A, Robakis NK.

Neurobiol Aging. 2016 Jun;42:41-9. doi: 10.1016/j.neurobiolaging.2016.02.028. Epub 2016 Mar 4.

PMID:
27143420
3.

Klotho Is a Neuroprotective and Cognition-Enhancing Protein.

Abraham CR, Mullen PC, Tucker-Zhou T, Chen CD, Zeldich E.

Vitam Horm. 2016;101:215-38. doi: 10.1016/bs.vh.2016.02.004. Epub 2016 Mar 22.

PMID:
27125744
4.

APOE*4 genotype is associated with altered levels of glutamate signaling proteins and synaptic co-expression networks in the prefrontal cortex in mild to moderate Alzheimer disease.

Sweet RA, MacDonald ML, Kirkwood CM, Ding Y, Schempf T, Jones-Laughner J, Kofler J, Ikonomovic MD, Lopez OL, Fitz NF, Koldamova R, Yates NA.

Mol Cell Proteomics. 2016 Apr 21. pii: mcp.M115.056580. [Epub ahead of print]

5.

Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.

Yang W, Zhou X, Zimmermann HR, Cavener DR, Klann E, Ma T.

Neurobiol Aging. 2016 May;41:19-24. doi: 10.1016/j.neurobiolaging.2016.02.005. Epub 2016 Feb 13.

PMID:
27103515
6.

Vaccination to Alzheimer disease. Is it a promising tool or a blind way?

Pohanka M.

Curr Med Chem. 2016 Apr 18. [Epub ahead of print]

PMID:
27087245
7.

Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.

Jahng GH, Oh J, Lee DW, Kim HG, Rhee HY, Shin W, Paik JW, Lee KM, Park S, Choe BY, Ryu CW.

J Alzheimers Dis. 2016 Mar 5;52(1):145-59. doi: 10.3233/JAD-150877.

PMID:
27060946
8.

A possible significant role of zinc and GPR39 zinc sensing receptor in Alzheimer disease and epilepsy.

Khan MZ.

Biomed Pharmacother. 2016 Apr;79:263-72. doi: 10.1016/j.biopha.2016.02.026. Epub 2016 Mar 11. Review.

PMID:
27044837
9.

[Changes in drug management of Alzheimer's disease in nursing homes: Impact of the media campaign against specific drugs for Alzheimer's disease].

Petit AE, Mangeard H, Chazard E, Puisieux F.

Encephale. 2016 Mar 30. pii: S0013-7006(16)00045-2. doi: 10.1016/j.encep.2015.03.006. [Epub ahead of print] French.

PMID:
27039155
10.

Hydrogen Proton Magnetic Resonance Spectroscopy in Multidomain Amnestic Mild Cognitive Impairment and Vascular Cognitive Impairment Without Dementia.

Chen SQ, Cai Q, Shen YY, Xu CX, Zhou H, Zhao Z.

Am J Alzheimers Dis Other Demen. 2016 Mar 14. pii: 1533317515628052. [Epub ahead of print]

PMID:
26980718
11.

Dopamine agonists rescue Aβ-induced LTP impairment by Src-family tyrosine kinases.

Yuan Xiang P, Janc O, Grochowska KM, Kreutz MR, Reymann KG.

Neurobiol Aging. 2016 Apr;40:98-102. doi: 10.1016/j.neurobiolaging.2016.01.008. Epub 2016 Jan 21.

PMID:
26973108
12.

The role of glial-specific Kir4.1 in normal and pathological states of the CNS.

Nwaobi SE, Cuddapah VA, Patterson KC, Randolph AC, Olsen ML.

Acta Neuropathol. 2016 Mar 9. [Epub ahead of print]

PMID:
26961251
13.

Hippocampal mGluR-LTD in health and disease: focus on the p38 MAPK and ERK1/2 pathways.

Sanderson TM, Hogg EL, Collingridge GL, Corrêa SA.

J Neurochem. 2016 Feb 28. doi: 10.1111/jnc.13592. [Epub ahead of print] Review.

PMID:
26923875
14.

Learning impairment by minimal cortical injury in a mouse model of Alzheimer׳s disease.

Zou J, Wang M, Uchiumi O, Shui Y, Ishigaki Y, Liu X, Tajima N, Akai T, Iizuka H, Kato N.

Brain Res. 2016 Apr 15;1637:56-63. doi: 10.1016/j.brainres.2016.02.017. Epub 2016 Feb 11.

PMID:
26876740
15.

JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease.

Rodriguez-Perdigon M, Solas M, Ramirez MJ.

J Alzheimers Dis. 2016 Jan 21;50(4):963-7. doi: 10.3233/JAD-150659.

PMID:
26836159
16.

An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.

Elkahloun AG, Hafko R, Saavedra JM.

Alzheimers Res Ther. 2016 Jan 28;8(1):5. doi: 10.1186/s13195-015-0167-5.

17.

Mesenchymal Stem Cells Preserve Working Memory in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Ruzicka J, Kulijewicz-Nawrot M, Rodrigez-Arellano JJ, Jendelova P, Sykova E.

Int J Mol Sci. 2016 Jan 25;17(2). pii: E152. doi: 10.3390/ijms17020152.

19.

Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease.

Osborn LM, Kamphuis W, Wadman WJ, Hol EM.

Prog Neurobiol. 2016 Jan 12. pii: S0301-0082(15)30021-6. doi: 10.1016/j.pneurobio.2016.01.001. [Epub ahead of print] Review.

PMID:
26797041
20.

NMDA receptor is involved in neuroinflammation in intracerebroventricular colchicine-injected rats.

Sil S, Ghosh T, Ghosh R.

J Immunotoxicol. 2016 Jan 20:1-16. [Epub ahead of print]

PMID:
26788903
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk